Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low molecular weight heparin treatment in pregnancy with intrauterine growth restriction
2011-000818-20Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of tinzaparin in intrauterine growth restriction (IUGR) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Difference in birth weight. Started Apr 2011; status: completed.
02
Drugs
tinzaparin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2011-000818-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000818-20.